SCHEMBL4730380

SCHEMBL4730380

COc1ccc(C(Cl)CC(C)=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
FFAR1 O14842 2/20 0.45
LDHA P00338 1/20 0.44
KMT2A Q03164 3/20 0.44
CNR2 P34972 1/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
PAX8 Q06710 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
MEN1 O00255 2/20 0.44
HPGD P15428 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6944967 0.89 L3MBTL1 (0.49) L3MBTL1FFAR1LDHAKMT2ACNR2
SCHEMBL15312717 0.87 FFAR1 (0.55) L3MBTL1FFAR1LDHAKMT2AATM
SCHEMBL6289377 0.86 TNF (0.52) L3MBTL1FFAR1LDHAKMT2ACNR2
SCHEMBL28293597 0.84 ACACB (0.48) KMT2ACNR2ALDH1A1TDP1NPC1
SCHEMBL3648264 0.84 RAB9A (0.43) L3MBTL1LDHAKMT2ACNR2ALDH1A1
SCHEMBL628797 0.81 LMNA (0.56) L3MBTL1FFAR1LDHAKMT2ACNR2
SCHEMBL4623899 0.81 ESR1 (0.46) KMT2AALDH1A1TSHRTDP1RAB9A
SCHEMBL5321358 0.81 BRD4 (0.50) FFAR1KMT2ATSHRMEN1LMNA
SCHEMBL6935978 0.81 STAT3 (0.46) L3MBTL1FFAR1KMT2ACNR2ALDH1A1
SCHEMBL8660435 0.81 POLB (0.42) L3MBTL1FFAR1KMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109748785-A Two aromatic hydrocarbon substituted propenone class compounds of one kind and preparation method and application 山东大学 2019-05-14 CN disclosed
EP-2582701-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2013-04-24 EP disclosed
WO-2011160084-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2011-12-22 WO disclosed
WO-2008034579-A1 2-HETEROCYCLYL-5-PHENOXYMETHYLPYRIDINE DERIVATIVES AS ANTICANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 WO disclosed
EP-1794153-A1 1,2,3-TRIAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS F. Hoffmann-Roche AG (CH) 2007-06-13 EP disclosed
WO-2006032453-A1 1,2,3 -TRIAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHITORS F.HOFFMANN-LA ROCHE AG (CH) 2006-03-30 WO disclosed
EP-1294671-A2 UTILISATION OF KETONES AS PRECURSORS OF ACTIVE COMPOUNDS FIRMENICH SA (CH) 2003-03-26 EP disclosed
WO-2001096272-A2 UTILISATION OF KETONES AS PRECURSORS OF ACTIVE COMPOUNDS FIRMENICH SA (CH) 2001-12-20 WO disclosed